Abstract
Host genetic factors may modify the risk of developing HIV-associated neurocognitive impairment (HIV-NCI), and genetic research has the potential to inform novel treatments for HIV-NCI. However, there is a need to better understand the acceptability of genetic testing among distinct populations of people living with HIV at increased risk for HIV-NCI, such as young people living with perinatally-acquired HIV (PHIV) in low- and middle-income countries (LMICs), to gauge the feasibility of genetic research within these populations. This pilot study evaluated the acceptability and feasibility of genetic testing to assess risk of future neurocognitive problems in fifty Thai adolescents and young adults (12-24 years; Mage=19.16; 52% female) with PHIV and demographically similar HIV-negative controls. Participants completed a survey assessing acceptability of and concerns about genetic testing and were asked to provide blood samples for genetic testing. Descriptive statistics and blood draw completion rates were produced and calculated. Reported concerns about genetic testing were grouped thematically and tallied. Independent t tests and chi-squares explored demographic differences between participants who reported concerns and peers. Results indicated 46 participants (92%) rated genetic testing as “acceptable” or “completely acceptable.” Eight participants (16%) reported concerns about genetic testing. The most common concerns were related to genetic information being shared or misused. Compared to peers, participants who reported concerns had more years of education and were more likely to have post-secondary schooling. Regarding completion rates, 49 participants (98%) agreed to genetic testing and provided blood samples. Overall, results support the acceptability and feasibility of incorporating genetic testing into research investigating HIV-NCI among adolescents and young adults in Thailand. Findings provide important considerations for planning future genetic studies among young people in Thailand and perhaps other LMICs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Columbia University's and the New York State Psychiatric Institute's HIV Center for Clinical and Behavioral Studies, a program funded by the National Institute of Mental Health (P30 MH043520, PI: Remien). This work was also supported by funding from a training grant from the National Institute of Mental Health (T32 MH019139, PI: Sandfort) and funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21 HD098035, PI: Robbins).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This work was conducted under ethical approval from the IRB at the New York State Psychiatric Institute and received a Certification of Ethical Clearance from the Human Experimentation Committee at the Research Institute for Health Sciences, Chiang Mai University.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding and Conflicts of Interest. This work was supported by funding from the National Institute of Health (P30 MH043520, PI: Remien; T32 MH019139, PI: Sandfort; R21 HD098035, PI: Robbins). Authors have no conflicts of interest related to this work to declare. Acknowledgments and declarations are included on the page immediately preceding references.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
